Furthermore, chemotherapy-naïve patients had elevated IL-33 expression, which decreased following neoadjuvant chemotherapy, suggesting that chemotherapy might reduce tumor aggressiveness by suppressing IL-33. This evidence concerns the gene IL33 and neoplasm.